Sept 20 (Reuters) - Virpax Pharmaceuticals Inc VRPX.O :
* VIRPAX TO DEVELOP INTRANASAL CANNABIDIOL PRODUCT FOR THE MANAGEMENT OF EPILEPSY IN ADULTS AND CHILDREN
* VIRPAX - ACQUIRED EXCLUSIVE WORLDWIDE RIGHTS FROM NANOMERICS TO USE NANOMERIC'S MET FOR NASAL DELIVERY OF CBD FOR MANAGEMENT OF EPILEPSY IN ADULTS, CHILDREN
Source text for Eikon: ID:nBwbHlsyfa Further company coverage: VRPX.O